Tech Company Financing Transactions
NGM Biopharmaceuticals Funding Round
NGM Biopharmaceuticals secured a $51 million Series B funding round on 3/15/2010. Backers included Prospect Venture Partners, Rho Ventures and The Column Group.
Transaction Overview
Prospect Venture Partners (David Schnell)
Rho Ventures (Mark Leschly)
The Column Group (David Goeddel)
Tichenor Ventures (McHenry Tichenor)
Company Information
San Francisco, CA 94080
USA
Management Team
Browse more venture capital transactions:
Prev: 3/15/2010: Hunch venture capital transaction
Next: 3/16/2010: Rollcast Energy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs